HLN
Haleon plcNYSEHealthcare$9.93-0.40%ClosedMarket Cap: $44.27B
As of 2026-04-06
Valuation
P/E (TTM)
32.57
PEG
0.41
P/B
2.06
P/S
4.03
EV/EBITDA
19.52
DCF Value
$20.50
FCF Yield
2.8%
Div Yield
1.5%
Margins & Returns
Gross Margin
61.5%
Operating Margin
18.8%
Net Margin
12.6%
ROE
6.4%
ROA
14.8%
ROIC
4.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $5.52B | 65.0% | $1.25B | $855.7M | $0.19 | — |
| FY 2025 | $10.79B | 64.8% | $2.42B | $1.63B | $0.36 | $0.18 |
| Q2 2025 | $5.48B | 64.5% | $1.20B | $806.0M | $0.18 | $0.12 |
| Q1 2025 | $2.74B | 64.5% | $601.5M | $403.0M | $0.09 | — |
| Q4 2024 | $5.54B | 61.4% | $1.05B | $716.0M | $0.16 | — |
| FY 2024 | $11.23B | 61.9% | $2.21B | $1.44B | $0.32 | $0.16 |
| Q3 2024 | $2.78B | 62.9% | $705.0M | $485.0M | $0.11 | $0.05 |
| Q2 2024 | $5.69B | 63.8% | $1.15B | $726.0M | $0.16 | — |
| Q1 2024 | $2.92B | 63.0% | $655.0M | $423.0M | $0.09 | $0.11 |
| Q4 2023 | $5.56B | 57.5% | $855.0M | $362.0M | $0.08 | — |
| FY 2023 | $11.30B | 61.6% | $2.00B | $1.05B | $0.24 | $0.10 |
| Q2 2023 | $5.74B | 61.9% | $1.14B | $687.0M | $0.15 | — |